American Society for Microbiology, Clinical and Vaccine Immunology, 5(17), p. 882-883, 2010
DOI: 10.1128/cvi.00038-10
Full text: Unavailable
ABSTRACT The plasmatic levels of 1,3-β- d -glucan (BDG) were >523 pg/ml in 4 children, 2 low-birth-weight neonates and 2 stem cell transplant recipients, with the following invasive fungal diseases (IFD) proven apart from this BDG test: 3 cases of Candida parapsilosis candidemias and 1 case of disseminated aspergillosis. The BDG test may be useful for identification of IFD in pediatrics.